Cargando…

Optimal functional outcome measures for assessing treatment for Dupuytren’s disease: a systematic review and recommendations for future practice

BACKGROUND: Dupuytren's disease of the hand is a common condition affecting the palmar fascia, resulting in progressive flexion deformities of the digits and hence limitation of hand function. The optimal treatment remains unclear as outcomes studies have used a variety of measures for assessme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ball, Catherine, Pratt, Anna L, Nanchahal, Jagdeep
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637830/ https://www.ncbi.nlm.nih.gov/pubmed/23575442 http://dx.doi.org/10.1186/1471-2474-14-131

Ejemplares similares

Systematic review of non-surgical treatments for early dupuytren’s disease
por: Ball, Catherine, et al.
Publicado: (2016)

Recent advances in the understanding of Dupuytren’s disease
por: Layton, Thomas, et al.
Publicado: (2019)

What are we measuring? A critique of range of motion methods currently in use for Dupuytren’s disease and recommendations for practice
por: Pratt, Anna L., et al.
Publicado: (2016)

What do we know about managing Dupuytren’s disease cost-effectively?
por: Dritsaki, Melina, et al.
Publicado: (2018)

Treatments for early-stage Dupuytren’s disease: an evidence-based approach
por: Nanchahal, Jagdeep, et al.
Publicado: (2023)

Cost-effectiveness of adalimumab for early-stage Dupuytren’s disease: an economic evaluation based on a randomized controlled trial and individual-patient simulation model
por: Dakin, Helen, et al.
Publicado: (2022)

Economic evaluation plan of a randomised controlled trial of intra-nodular injection of anti-TNF and placebo among patients with early Dupuytren’s disease: Repurposing Anti-TNF for Treating Dupuytren’s Disease (RIDD)
por: Png, May Ee, et al.
Publicado: (2019)

Anti-tumour necrosis factor therapy for early-stage Dupuytren’s disease (RIDD): a phase 2b, randomised, double-blind, placebo-controlled trial
por: Nanchahal, Jagdeep, et al.
Publicado: (2022)

Study protocol: A multi-centre, double blind, randomised, placebo-controlled, parallel group, phase II trial (RIDD) to determine the efficacy of intra-nodular injection of anti-TNF to control disease progression in early Dupuytren’s disease, with an embedded dose response study.
por: Nanchahal, Jagdeep, et al.
Publicado: (2017)

Anti-Tumour Necrosis Factor Therapy for Dupuytren's Disease: A Randomised Dose Response Proof of Concept Phase 2a Clinical Trial
por: Nanchahal, Jagdeep, et al.
Publicado: (2018)

A Genome-wide Association Study of Dupuytren Disease Reveals 17 Additional Variants Implicated in Fibrosis
por: Ng, Michael, et al.
Publicado: (2017)

Dupuytren's Contracture
por: Sood, Aditya, et al.
Publicado: (2013)

Dupuytren's contracture
por: Raina, Sujeet, et al.
Publicado: (2012)

Outcomes of Management of Recurrent Dupuytren Contracture: A Systematic Review and Meta-analysis
por: Wong, Chloe R., et al.
Publicado: (2021)

Paediatric Dupuytren's disease
por: Korambayil, Pradeoth Mukundan, et al.
Publicado: (2011)

Dupuytren's Treatment of Scrofula
Publicado: (1830)

Dupuytren's Contraction and Dysparathyreoidism
Publicado: (1932)

Dupuytren’s Contraction of the Fingers
Publicado: (1882)

Imaging for Dupuytren disease: a systematic review of the literature
por: Molenkamp, Sanne, et al.
Publicado: (2019)

Report on the Evidence-Based Practice Committee’s Survey on Dupuytren Disease
por: Ahmad, Farhan, et al.
Publicado: (2021)

Medical Classics, Guillaume Dupuytren
Publicado: (1940)

Sorafenib in Dupuytren and Ledderhose Disease
por: Schoenfeld, Joshua D, et al.
Publicado: (2022)

Assessment of palmar subcutaneous tissue vascularization in patients with Dupuytren’s contracture
por: Shchudlo, Nathalia, et al.
Publicado: (2018)

Dynamic Manugraphy as a Promising Tool to Assess the Outcome of Limited Aponeurectomy in Patients With Dupuytren's Contracture
por: Garkisch, Angelina, et al.
Publicado: (2021)

The application of spatial measures to analyse health service accessibility in Australia: a systematic review and recommendations for future practice
por: Wood, Sarah M., et al.
Publicado: (2023)

A new bromelain-based enzyme for the release of Dupuytren’s contracture: Dupuytren’s enzymatic bromelain-based release
por: Rubin, G., et al.
Publicado: (2016)

Dupuytren's Disease: Review of the Current Literature
por: Khashan, Morsi, et al.
Publicado: (2011)

Dupuytren's: a systems biology disease
por: Rehman, Samrina, et al.
Publicado: (2011)

The Rationale for Treating the Nodule in Dupuytren’s Disease
por: Ketchum, Lynn D.
Publicado: (2015)

M. Dupuytren's Treatment of Specks on the Cornea
Publicado: (1830)

M. Dupuytren on Varicose Aneurism, with Criticisms
Publicado: (1830)

Dupuytren’s disease and the risk of malignant neoplasms
por: Żyluk, Andrzej, et al.
Publicado: (2014)

Dupuytren's Disease: the Vikings Disease in Koreans
por: Gong, Hyun Sik
Publicado: (2018)

Cytokine Targeted Therapy for Dupuytren's Disease
por: Satish, Latha
Publicado: (2018)

Epidemiological analysis of patients with Dupuytren's disease()
por: Mansur, Henrique Gonçalves, et al.
Publicado: (2017)

Surgical treatment results for dupuytren's disease
por: Aykut, Serkan, et al.
Publicado: (2017)

Dupuytren’s Contracture with Secondary Ulnar Neuropathy
por: Ng, Chen Fei
Publicado: (2020)

Dupuytren's Contracture: The Readability of Online Information
por: Hosseinzadeh, Shayan, et al.
Publicado: (2021)

EPIDEMIOLOGICAL ASPECTS OF DUPUYTREN'S DISEASE IN BRAZIL
por: Nakamoto, Hugo Alberto, et al.
Publicado: (2022)

Dutch Multidisciplinary Guideline on Dupuytren Disease
por: Kemler, Marius A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fnv7otlc1kr7ddbhs443b7l7nl